Luspatercept for Clonal Cytopenias of Uncertain Significance

Clinical trial NCT06788691 · RECRUITING

Trial details

NCT number: NCT06788691
Sponsor: Weill Medical College of Cornell University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CCUS Clonal Cytopenia of Undetermined Significance Anemia Leukopenia Thrombocytopenia Neutropenia

Start date: 2025-03-25
Primary completion: 2027-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.